Stay updated on Dolutegravir for HIV Treatment Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.

Latest updates to the Dolutegravir for HIV Treatment Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing the previous v3.4.1. This update appears cosmetic and does not alter study content.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page. This appears to be a backend/version update with no changes to the visible study information.SummaryDifference0.0%

- Check32 days agoChange DetectedUI updates include showing/hiding glossary controls and small metadata label changes (e.g., capitalization of 'Last Update Submitted that Met QC Criteria' to 'Last Update Submitted that met QC Criteria', and 'No FEAR Act Data' to 'No FEAR Act data'), with the Revision updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor metadata/version update with no substantive changes to the page content, study details, locations, or patient information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded a centralized Locations section with regional site listings (Arizona, California, Colorado, Brazil, Canada, Germany, etc.) and removed the prior per-location subsections. Page revision updated to v3.3.3.SummaryDifference2%

- Check90 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir for HIV Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.